Method and treatment composition for decreasing patient time in catabolic state after traumatic injury
US5700775A · kind A · utility
12Cited by
4References
20Claims
0Family size
Inventors
Key dates
| Filing date | Mar 24, 1995 |
| Grant date | Dec 23, 1997 |
| Priority date | — |
| Expiry date | Mar 24, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/25
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of decreasing patient time in a catabolic state after a traumatic injury. The patient is administered systemically human growth hormone releasing factor or a biologically active analog of human growth hormone releasing factor. Administration in the case of voluntary traumatic injury such as surgery occurs just prior to commencing the surgery and thereafter continuing until recovery. In this way the time in a catabolic state is significantly decreased, and the patient moves more quickly to desired anabolic state necessary for recovery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.